Close

Regulatory Compliance

Staying Ahead of E-prescribing Requirements

Are Your Systems Compliant?

If your platform isn’t compliant with the latest industry and regulatory certifications, your customers are at risk, putting your customer retention in jeopardy as well.

Cures Act Final Rule
• By end of 2023, must meet electronic health information (EHI) export criteria
• Must use APIs to provide access to medical records
• Risk $1M fine for each violation of Information Blocking Rule1

State EPCS and PDMP Mandates
DrFirst has been at the forefront of electronic prescribing of controlled substances (EPCS) since it sent the nation’s first electronic prescription of a controlled substance. With EPCS legalized nationally, a majority of states have since mandated the use of EPCS for all controlled substances. View Map

Federal EPCS Compliance
The Centers for Medicare & Medicaid Services (CMS) delayed the mandate deadline to January 1, 2023, for the SUPPORT Act. This requires all controlled substance prescriptions under Medicare’s Part D drug plan to be transmitted electronically.

With standards and regulatory requirements changing constantly, extensive legal, compliance, and product development resources are necessary to stay current. This burden challenges your roadmap commitments, competing priorities, and already scare resources.

Are Your Systems Compliant?

If your platform isn’t compliant with the latest industry and regulatory certifications, your customers are at risk, putting your customer retention in jeopardy as well.

Cures Act Final Rule

  • By end of 2023, must meet electronic health information (EHI) export criteria
  • Must use APIs to provide access to medical records
  • Risk $1M fine for each violation of Information Blocking Rule1

State EPCS and PDMP Mandates

DrFirst has been at the forefront of electronic prescribing of controlled substances (EPCS) since it sent the nation’s first electronic prescription of a controlled substance. With EPCS legalized nationally, a majority of states have since mandated the use of EPCS for all controlled substances. View Map

Federal EPCS Compliance

The Centers for Medicare & Medicaid Services (CMS) delayed the mandate deadline to January 1, 2023, for the SUPPORT Act. This requires all controlled substance prescriptions under Medicare’s Part D drug plan to be transmitted electronically.

With standards and regulatory requirements changing constantly, extensive legal, compliance, and product development resources are necessary to stay current. This burden challenges your roadmap commitments, competing priorities, and already scare resources.

Trust a Reliable Partner

Partners who say our software integrations improved their regulatory compliance and quality measures2

3 Big Updates: Get Ready for the Next Regulatory Cycle

  1. CMS is proposing an upgrade from SCRIPT 2017 to the 2022 version of the SCRIPT standard, potentially affecting new prescriptions, inbound pharmacy requests, real-time benefit transactions, and prior authorization.  
  2. The Consolidated Appropriations Act (Omnibus bill) will add training requirements to the DEA registration process and remove the federal X-Waiver requirement to prescribe medications for opioid use disorder. 
  3. The end of the Public Health Emergency in response to the COVID-19 pandemic will restore the requirement for in-person visits prior to treating patients for controlled substance abuse.

Meet Customer Needs and Regulatory Requirements

Outsource your regulatory challenges by integrating DrFirst’s solutions seamlessly with existing workflows to: 

  • Innovate faster
  • Generate new revenue streams
  • Gain back product and technical resources for your strategic initiatives

Recommended Resources

Contact Us